S5U-14722-29458
4 vaccinations
3 coded responses
25 check-ins
3 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 276 / NC
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
3Y2-25283-60776
Child or adolescent in my care · Female · 2022-06-28
Timeline
-
2020-12-30
Registered in v-safe
-
2020-12-30
Dose 1 — Pfizer-BioNTech
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-06
- 2021-01-13
-
2021-01-16
Dose 2 — Pfizer-BioNTech
-
2021-01-16
Survey response — day 0, dose 2MedDRA: Migraine — Feeling: Fair · Site: Pain · Headache · Be unable to do your normal daily activitiesFree text: migraineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-16
Report sent to call center — day 0, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-21
- 2021-01-22
- 2021-01-23
- 2021-01-30
- 2021-02-06
- 2021-02-13
- 2021-02-20
- 2021-02-27
- 2021-04-17
- 2021-07-17
-
2021-10-14
Dose 3 — Pfizer-BioNTech
-
2022-01-16
Survey response — 12 months, dose 2MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-01-16
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-01-17
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-09-23
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-10-14
Survey response — 12 months, dose 3MedDRA: Headache — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Persistent headachesMedDRA releases: 2024-11 · check-in free text available
-
2022-10-14
Report sent to call center — 12 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-17
- 2023-03-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Pfizer-BioNTech | |
| 2 | 2021-01-16 | Pfizer-BioNTech | |
| 3 | 2021-10-14 | Pfizer-BioNTech | No |
| 4 | 2022-09-23 | Pfizer-BioNTech | Flu |
Call center
4 call center cases
1 successful · 1 unsuccessful · 2 priority 2/3 (triaged and no follow up)
Free text
Release 2 — day 0, dose 2
Systemic reaction (other): migraine
Release 10 — 12 months, dose 2
Symptoms: Pregnancy
Release 12 — 12 months, dose 3
Symptoms: Persistent headaches
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SRO | Migraine | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release